Pyrazolo[1,5-c]quinazoline derivatives and their simplified analogues as adenosine receptor antagonists: Synthesis, structure-affinity relationships and molecular modeling studies

被引:43
|
作者
Catarzi, Daniela [1 ]
Colotta, Vittoria [1 ]
Varano, Flavia [1 ]
Poli, Daniela [1 ]
Squarcialupi, Lucia [1 ]
Filacchioni, Guido [1 ]
Varani, Katia [2 ]
Vincenzi, Fabrizio [2 ]
Borea, Pier Andrea [2 ]
Dal Ben, Diego [3 ]
Lambertucci, Catia [3 ]
Cristalli, Gloria [3 ]
机构
[1] Univ Florence, Dipartimento Sci Farmaceut, Lab Progettaz Sintesi & Studio Eterocicli Biologi, I-50019 Sesto Fiorentino, FI, Italy
[2] Univ Ferrara, Dipartimento Med Clin & Sperimentale, Sez Farmacol, I-44100 Ferrara, Italy
[3] Univ Camerino, Sch Pharm, Med Chem Unit, I-62032 Camerino, MC, Italy
关键词
G protein-coupled receptors; Adenosine receptor antagonists; Pyrazoloquinazolines; Tricyclic heteroaromatic systems; Ligand-receptor modeling studies; FORCE-FIELD; PHARMACOLOGICAL EVALUATION; A(2A) RECEPTOR; CONFORMATIONAL ENERGIES; BIOLOGICAL EVALUATION; CRYSTAL-STRUCTURE; BINDING-ACTIVITY; POTENT; LIGAND; MMFF94;
D O I
10.1016/j.bmc.2012.10.031
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A number of 5-oxo-pyrazolo[1,5-c]quinazolines (series B-1), bearing at position-2 the claimed (hetero)aryl moiety (compounds 1-8) but also a carboxylate group (9-14), were designed as hA(3) AR antagonists. This study produced some interesting compounds endowed with good hA(3) receptor affinity and high selectivity, being totally inactive at all the other AR subtypes. In contrast, the corresponding 5-ammino derivatives (series B-2) do not bind or bind with very low affinity at the hA(3) AR, the only exception being the 5-N-benzoyl compound 19 that shows a hA(3) K-i value in the high mu-molar range. Evaluation of the synthetic intermediates led to the identification of some 5(3)-(2-aminophenyl)-3(5)-(hetero)arylpyrazoles 20-24 with modest affinity but high selectivity toward the hA(3) AR subtype. Molecular docking of the herein reported tricyclic and simplified derivatives was carried out to depict their hypothetical binding mode to our model of hA(3) receptor. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:283 / 294
页数:12
相关论文
共 50 条
  • [21] Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]-pyrimidine derivatives as highly potent and selective human A3 adenosine receptor antagonists
    Baraldi, PG
    Cacciari, B
    Romagnoli, R
    Spalluto, G
    Klotz, KN
    Leung, E
    Varani, K
    Gessi, S
    Merighi, S
    Borea, PA
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (22) : 4473 - 4478
  • [22] QSAR of adenosine receptor antagonists: Exploring physicochemical requirements for binding of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives with human adenosine A3 receptor subtype
    Kishore, D. Pran
    Balakumar, C.
    Rao, A. Raghuram
    Roy, Partha Pratim
    Roy, Kunal
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (02) : 818 - 823
  • [23] Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: Potent and selective A(2A) adenosine antagonists
    Baraldi, PG
    Cacciari, B
    Spalluto, G
    Villatoro, MJPDIY
    Zocchi, C
    Dionisotti, S
    Ongini, E
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (05) : 1164 - 1171
  • [24] Fluorosulfonyl- and bis-(β-chloroethyl)amino-phenylamino functionalized pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives:: Irreversible antagonists at the human A3 adenosine receptor and molecular modeling studies
    Baraldi, PG
    Cacciari, B
    Moro, S
    Romagnoli, R
    Ji, XD
    Jacobson, KA
    Gessi, S
    Borea, PA
    Spalluto, G
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (17) : 2735 - 2742
  • [25] A novel class of pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A3 adenosine receptor antagonists
    Federico, Stephanie
    Spalluto, Giampiero
    Klotz, Karl-Norbert
    Cacciari, Barbara
    Moro, Stefano
    Morizzo, Erika
    PURINERGIC SIGNALLING, 2010, 6 (01) : 79 - 80
  • [26] Synthesis and Structure-Activity Relationships of Pyrazolo[1,5-a]pyridine Derivatives: Potent and Orally Active Antagonists of Corticotropin-Releasing Factor 1 Receptor
    Takahashi, Yoshinori
    Hibi, Shigeki
    Hoshino, Yorihisa
    Kikuchi, Koichi
    Shin, Kogyoku
    Murata-Tai, Kaoru
    Fujisawa, Masae
    Ino, Mitsuhiro
    Shibata, Hisashi
    Yonaga, Masahiro
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (11) : 5255 - 5269
  • [27] Synthesis of pyrazolo[1,5-c]quinazoline derivatives through the copper-catalyzed domino reaction ofo-alkenyl aromatic isocyanides with diazo compounds
    Liu, Lu
    Li, Lei
    Mao, Shukuan
    Wang, Xin
    Zhou, Ming-Dong
    Zhao, Yu-long
    Wang, He
    CHEMICAL COMMUNICATIONS, 2020, 56 (55) : 7665 - 7668
  • [28] Potent, selective, and orally active adenosine A2A receptor antagonists:: Arylpiperazine derivatives of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
    Neustadt, Bernard R.
    Hao, Jinsong
    Lindo, Neil
    Greenlee, William J.
    Stamford, Andrew W.
    Tulshian, Deen
    Ongini, Ennio
    Hunter, John
    Monopoli, Angela
    Bertorelli, Rosalia
    Foster, Carolyn
    Arik, Leyla
    Lachowicz, Jean
    Ng, Kwokei
    Feng, Kung-I
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (05) : 1376 - 1380
  • [29] Structure-Affinity Relationships and Structure-Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A3 Receptor Antagonists
    Xia, Lizi
    Burger, Wessel A. C.
    van Veldhoven, Jacobus P. D.
    Kuiper, Boaz J.
    van Duijl, Tirsa T.
    Lenselink, Eelke B.
    Paasman, Ellen
    Heitman, Laura H.
    IJzerman, Adriaan P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (17) : 7555 - 7568
  • [30] Substituted 1, 3, 5-triazine derivatives as adenosine A2A receptor antagonists: Synthesis, structure-activity relationships and molecular modelling studies
    Singh, Udaya
    Bhat, Hans
    MOVEMENT DISORDERS, 2014, 29 : S62 - S62